/PRNewswire/ GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous,.
The Chromatography Resin Industry is poised for a remarkable ascent, with market share value expected to surge from US$ 1.4 billion in 2023 to an impressive US$ 2.8 billion by 2033. This substantial growth trajectory is underpinned by a projected compound annual growth rate (CAGR) of 7.5% from 2023 to 2033.This rema.
Anticipated to surge from US$ 1.4 billion in 2023 to an impressive US$ 2.8 billion by 2033, the market share value of the chromatography resin industry is on a remarkable growth trajectory. This expansion is driven by a projected compound annual growth rate (CAGR) of 7.5% from 2023 to 2033. The pivotal factors prope.
The net worth of the chromatography resin industry’s market share is expected to increase from US$ 1.4 billion in 2023 to more than US$ 2.8 billion by 2033. From 2023 to 2033, the market for Chromatography Resin is expected to grow at a 7.5% CAGR. Growth in the market is primarily driven by an increase in biosimilar.
We sit down with Subhasis Banerjee Ph.D., Principal Application Expert, APAC Bioprocessing to talk about viral safety, the Covid-19 pandemic, and the regulatory landscape for vaccines in India., Technology & Science News, Times Now